Business News

Sterling Invests in Expansion of Integrated ADC Services

May 31, 2024

Sterling is strengthening its development and manufacturing services for ADCs with a dedicated GMP suite at its Wisconsin facility.

Lilly Raises Investment in Indiana Site to $9 Billion to Expand API Manufacturing

May 30, 2024

Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.

Johnson & Johnson to Acquire Global Rights to Numab Therapeutics’ Bispecific Antibody for Atopic Dermatitis in $1.25 Billion Deal

May 30, 2024

Johnson & Johnson will gain NM26, a bispecific antibody targeting atopic dermatitis, via the acquisition of a wholly owned subsidiary of Numab Therapeutics.

AGC Biologics Partners with BioConnection to Offer Biopharma Drug Substance and Drug Product Development and Manufacturing

May 25, 2024

The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.

Biogen to Acquire HI-Bio in Deal Worth Potentially Up to $1.8 Billion

May 24, 2024

With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.

Merck KGaA Announces $600 Million Deal to Acquire Mirus Bio

May 24, 2024

With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.

How TekniPlex is Expanding to Support Innovative Solutions in Materials Science

May 17, 2024

TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.

IMA Life North America Breaks Ground on New Facility in Tonawanda, NY

May 17, 2024

The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.

New Cell Factory Box Launched by ProPharma and PBL for Automated CGT Manufacturing

May 07, 2024

ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.

SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy

April 27, 2024

SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.